mavoglurant (BioDeep_00000784533)

   


代谢物信息卡片


mavoglurant

化学式: C19H23NO3 (313.1678)
中文名称: Mavoglurant
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=CC(=CC=C1)C#CC2(CCCC3C2CCN3C(=O)OC)O
InChI: InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1

描述信息

C78272 - Agent Affecting Nervous System
Mavoglurant (AFQ056) is a potent, selective, non-competitive and orally active mGluR5 antagonist, with an IC50 of 30 nM. Mavoglurant shows a >300 fold selectivity for the mGluR5 over all targets (238) tested. Mavoglurant can be used for the research of Fragile X syndrome (FXS), and L-dopa induced dyskinesias in Parkinson's disease[1][1][2]. Mavoglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

同义名列表

2 个代谢物同义名

mavoglurant; AFQ056



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Kirstie A Bennett, Eugenia Sergeev, Cliona P MacSweeney, Geor Bakker, Anne E Cooper. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. The Journal of pharmacology and experimental therapeutics. 2021 04; 377(1):157-168. doi: 10.1124/jpet.120.000371. [PMID: 33541889]
  • Mike Ufer, Alexandros Sagkriotis, Atish Salunke, Subramanian Ganesan, Anne Tisserant, Angela Dodman, Emilie Voltz, Ralph Woessner, Pierre Jordaan, Eric Legangneux. Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056). Clinical therapeutics. 2016 Dec; 38(12):2589-2597. doi: 10.1016/j.clinthera.2016.10.007. [PMID: 27823869]
  • Thierry Wendling, Nikolaos Tsamandouras, Swati Dumitras, Etienne Pigeolet, Kayode Ogungbenro, Leon Aarons. Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data. The AAPS journal. 2016 Jan; 18(1):196-209. doi: 10.1208/s12248-015-9840-7. [PMID: 26538125]
  • Thierry Wendling, Swati Dumitras, Kayode Ogungbenro, Leon Aarons. Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics. Journal of pharmacokinetics and pharmacodynamics. 2015 Dec; 42(6):639-57. doi: 10.1007/s10928-015-9430-4. [PMID: 26231433]
  • Rama Sivasubramanian, Abhijit Chakraborty, Marie-Laure Rouzade-Dominguez, Srikanth Neelakantham, Annamaria Jakab, Tjeert Mensinga, Eric Legangneux, Ralph Woessner, Mike Ufer. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women. International journal of clinical pharmacology and therapeutics. 2015 Jul; 53(7):550-6. doi: 10.5414/cp202321. [PMID: 25943176]
  • Thierry Wendling, Kayode Ogungbenro, Etienne Pigeolet, Swati Dumitras, Ralph Woessner, Leon Aarons. Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects. Pharmaceutical research. 2015 May; 32(5):1764-78. doi: 10.1007/s11095-014-1574-1. [PMID: 25425054]
  • Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty, Piet Swart. Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects. Drug metabolism and disposition: the biological fate of chemicals. 2013 Sep; 41(9):1626-41. doi: 10.1124/dmd.112.050716. [PMID: 23775850]
  • Annamaria Jakab, Serge Winter, Marc Raccuglia, Frank Picard, Swati Dumitras, Ralph Woessner, Sanket Mistry, Jayraj Chudasama, Swati Guttikar, Olivier Kretz. Validation of an LC-MS/MS method for the quantitative determination of mavoglurant (AFQ056) in human plasma. Analytical and bioanalytical chemistry. 2013 Jan; 405(1):215-23. doi: 10.1007/s00216-012-6456-y. [PMID: 23064707]